# Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)

> **NCT01099124** · NA · COMPLETED · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 25 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** M2ES

## Key facts

- **NCT ID:** NCT01099124
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-07
- **Final completion:** 2011-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099124, "Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01099124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*